D441 Medical Dosage Calculations and Pharmacology - Set 4 - Part 2

Correct Answer: Topical drug administration

Option a is correct because topical administration involves applying medication directly to and absorbing it through the skin, may produce local or systemic effects, and includes patches, ointments, creams, lotions, and gels for patients who cannot take oral medications. Option b is incorrect because enteral administration involves the gastrointestinal tract through oral forms like capsules, tablets, and suppositories, which would not be appropriate for a patient who is actively experiencing severe nausea and vomiting. Option c is incorrect because parenteral administration refers to medications not ingested or introduced through the gastrointestinal system and includes injections, inhalation, and nasal routes, not medicated patches applied directly to the skin surface. Option d is incorrect because sublingual administration involves placing medication under the tongue for absorption through oral mucous membranes, which is an enteral route and would likely be affected by the patient�

Correct Answer: Enteral administration route

Option d is correct because enteral administration includes any medication that involves the gastrointestinal tract, and the most common oral route has alternatives including rectal, nasogastric tube, sublingual, and buccal delivery methods. Option a is incorrect because topical administration involves applying medications directly to the skin for absorption, using forms like patches, ointments, and creams, not delivering drugs through a nasogastric tube into the gastrointestinal tract. Option b is incorrect because parenteral administration specifically refers to medications that are not ingested or introduced by the gastrointestinal system, which is the opposite of delivering medication directly into the stomach via nasogastric tube. Option c is incorrect because intravenous administration delivers medication directly into the bloodstream through a vein, which is a parenteral route and completely bypasses the gastrointestinal tract that the nasogastric tube feeds into.

Correct Answer: Parenteral administration method

Option b is correct because parenteral medications are not ingested or introduced through the gastrointestinal system, and this category includes injectable routes like subcutaneous, intravenous, intramuscular, and intradermal, along with topical, ophthalmic, and inhaled routes. Option a is incorrect because enteral administration specifically involves medications that travel through the gastrointestinal tract, including oral, rectal, sublingual, and buccal routes, which is the opposite of a subcutaneous injection bypassing that system. Option c is incorrect because topical administration refers specifically to medications applied directly to the skin surface for absorption, such as patches, creams, and ointments, not medications delivered beneath the skin through needle injection. Option d is incorrect because buccal administration involves placing medication between the cheek and gum for absorption through oral mucous membranes, which is an enteral route using the gastrointestinal sy

Correct Answer: Enteral oral administration

Option c is correct because enteral administration involves the gastrointestinal tract, with oral being the most common route of administration, using forms like capsules, tablets, enemas, and suppositories to deliver medication for absorption. Option a is incorrect because parenteral administration specifically refers to medication routes that bypass the gastrointestinal tract entirely, including injections, inhalation, nasal sprays, and ophthalmic drops, none of which involve swallowing capsules. Option b is incorrect because topical administration delivers medication directly through the skin using patches, ointments, creams, lotions, or gels, and does not involve swallowing capsules for gastrointestinal tract absorption. Option d is incorrect because inhalation administration delivers medication directly into the lungs through breathing, which is classified as a parenteral route that completely bypasses the gastrointestinal tract and oral swallowing process.

Correct Answer: Specific formulation and drug design

Option a is correct because topical medications applied directly to the skin and absorbed through it may produce either local or systemic effects, and whether the effect is localized or body-wide depends on how the specific drug formulation is designed. Option b is incorrect because a patient's history with oral medications does not determine whether a topical medication produces local versus systemic effects, since topical drugs bypass the gastrointestinal tract and work through skin absorption mechanisms. Option c is incorrect because verbal instructions from a prescriber tell the patient how and where to apply the medication but do not change the pharmacological design that determines whether the drug produces local or systemic therapeutic effects. Option d is incorrect because topical medications are absorbed through the skin, not through the gastrointestinal tract, making gastrointestinal absorption rate irrelevant to determining whether a topical drug provides local or syste

Correct Answer: Antagonist drug

Option c is correct because an antagonist acts against and blocks an action by attaching to opioid receptors without activating them, causing no opioid effect itself while blocking full agonist opioids. Naloxone is a classic antagonist example. Option a is incorrect because a full agonist binds to receptors and produces a chemical reaction that enhances or creates a drug effect, which is the opposite of blocking receptor activity to reverse an opioid overdose situation. Option b is incorrect because a partial agonist binds to and activates a receptor but only produces partial efficacy compared to a full agonist, rather than completely blocking receptor activity to reverse overdose effects as naloxone does. Option d is incorrect because synergism describes when two agonist drugs taken together produce a combined effect greater than either alone, which is the opposite of the receptor-blocking, effect-reversing action described in this emergency scenario.

Correct Answer: Synergism between agonists

Option d is correct because synergism occurs when a drug is taken with another drug so the two together can be more effective than each would be alone, and agonists that attach to brain receptors and produce chemical reactions create this enhanced effect. Option a is incorrect because antagonism involves a drug that makes another drug less effective by blocking receptor activity, which produces a reduced or eliminated effect rather than the enhanced combined therapeutic effect described in this scenario. Option b is incorrect because partial agonist activation produces only partial efficacy at a receptor compared to a full agonist, and this concept alone does not explain the enhanced combined therapeutic effect of two drugs taken simultaneously together. Option c is incorrect because receptor blocking is the mechanism of antagonist drugs that attach to receptors without activating them to prevent other drugs from working, which is the opposite of the enhanced combined effect described

Correct Answer: Partial agonist medication

Option a is correct because partial agonists bind to and activate a given receptor but only have partial efficacy at that receptor compared to a full agonist, meaning the patient gets some therapeutic effect but not the maximum possible response. Option b is incorrect because a full antagonist blocks receptors without activating them at all, producing no therapeutic effect of its own, rather than providing the reduced but still present pain relief described in this patient's new medication. Option c is incorrect because a complete agonist would fully activate the receptor and produce the maximum possible therapeutic response, not the limited partial effect that the prescriber specifically described to the patient about their medication. Option d is incorrect because synergistic combination therapy involves two drugs working together to produce an enhanced combined effect, not a single medication that partially activates receptors with reduced efficacy compared to stronger alternat

Correct Answer: Antagonist reducing effectiveness

Option b is correct because an antagonist makes another drug less effective, and in this case the antibiotic acts as an antagonist to birth control pills by reducing their contraceptive effectiveness, as noted with some antibiotic interactions. Option a is incorrect because an agonist enhances or produces a drug effect by attaching to receptors and triggering chemical reactions, which is the opposite of the antibiotic reducing the birth control pill's intended contraceptive effectiveness. Option c is incorrect because a partial agonist activates receptors with reduced efficacy compared to a full agonist, and adding partial benefit does not describe the pharmacist's warning about decreased contraceptive reliability during antibiotic use. Option d is incorrect because a synergist would increase the combined therapeutic potency of drugs taken together, which is the opposite of the antibiotic reducing and undermining the effectiveness of the patient's oral birth control pill

Correct Answer: Agonist, partial agonist, antagonist

Option d is correct because agonists fully activate receptors producing maximum chemical reactions, partial agonists activate the same receptors with only partial efficacy, and antagonists block receptors entirely without activating them or producing any opioid-like effect. Option a is incorrect because this sequence places antagonist first and agonist last, which reverses the correct order since the first description involves full receptor activation with maximum response, not blocking receptors without producing any effect. Option b is incorrect because this sequence incorrectly starts with partial agonist and places antagonist second, when the first description clearly refers to full activation with maximum response and the second describes reduced intensity activation. Option c is incorrect because this sequence places antagonist in the second position, but the second description involves activating receptors with reduced intensity, which describes a partial agonist, not an antagon

Correct Answer: Pharmacokinetics of the drug

Option a is correct because pharmacokinetics is the study of how drugs move through the body during absorption, distribution, metabolism, and excretion, which exactly describes the journey of the medication through the patient's body systems. Option b is incorrect because pharmacodynamics studies the effect of a drug on the body, including curative, prophylactic, diagnostic, palliative, replacement, and destructive actions, not how the drug physically moves through the body's systems. Option c is incorrect because pharmacotherapeutics is the study of the therapeutic uses and effects of drugs, focusing on clinical applications and treatment outcomes rather than the physical journey of absorption, distribution, metabolism, and excretion. Option d is incorrect because drug scheduling classification organizes controlled substances into categories based on abuse potential and accepted medical use under the Controlled Substances Act, not the pharmacological movement of drugs throug

Correct Answer: Passive diffusion process

Option c is correct because passive diffusion moves drugs from areas of high concentration to low concentration, and water-soluble molecules pass easily through membrane channels or pores without requiring any energy or carrier protein assistance. Option a is incorrect because active transport moves drugs from areas of low concentration to high concentration through impermeable membranes using active energy, which is the opposite of the no-energy, high-to-low concentration movement described here. Option b is incorrect because facilitated diffusion, while also moving from high to low concentration, specifically involves larger molecules that require the help of carrier proteins to pass through membranes, unlike the simple channel-based passage described. Option d is incorrect because pharmacodynamic drug action refers to the effects a drug produces on the body such as curative, prophylactic, or palliative actions, not the physical mechanism by which drug molecules cross cell membranes.

Correct Answer: Palliative drug action

Option b is correct because palliative pharmacodynamic action treats symptoms to make the patient more comfortable without curing the underlying disease, focusing specifically on improving quality of life and reducing discomfort during illness. Option a is incorrect because curative drug action is intended to cure or treat the underlying problem itself, not merely manage symptoms for comfort, which means it has a fundamentally different therapeutic goal than the medication described here. Option c is incorrect because prophylactic drug action prevents a disease or problem from occurring in the first place, such as vaccines, rather than treating existing symptoms to improve comfort for a patient already experiencing illness. Option d is incorrect because diagnostic drug action helps identify and diagnose a disease or condition through testing procedures, not treat symptoms or improve comfort for patients already experiencing a known illness and its associated discomfort.

Correct Answer: Facilitated diffusion process

Option d is correct because facilitated diffusion is a type of passive diffusion where larger molecules move from high to low concentration with the help of carrier proteins, similar to passive diffusion but required for molecules too large for simple channels. Option a is incorrect because active transport moves drugs from low concentration to high concentration areas through impermeable membranes using active cellular energy, which is the opposite of the energy-free, high-to-low concentration movement described here. Option b is incorrect because simple passive diffusion involves water-soluble or lipid-soluble molecules that can easily pass through membrane channels or pores without assistance, not the larger molecules that specifically require carrier protein help to cross. Option c is incorrect because pharmacotherapeutic drug action refers to the study of therapeutic uses and effects of drugs in clinical treatment, not a cellular transport mechanism by which drug molecules physica

Correct Answer: Active transport mechanism

Option a is correct because active transport moves drugs from areas of low concentration to high concentration through impermeable membranes using active cellular energy, which is the only mechanism that allows movement against the natural concentration gradient. Option b is incorrect because facilitated diffusion moves molecules from high to low concentration using carrier proteins without requiring cellular energy, making it unable to transport drugs against the concentration gradient as described in this scenario. Option c is incorrect because passive diffusion also moves substances from high to low concentration through channels or across membranes without energy expenditure, and cannot drive drugs against their natural concentration gradient as observed here. Option d is incorrect because pharmacodynamic drug response describes the effects a drug has on the body such as curative or prophylactic actions, not the cellular transport mechanism by which drug molecules cross impermeable

Correct Answer: Chemical drug name

Option b is correct because the chemical name is the first name assigned to a drug, showing the mix of chemicals being studied, and a-acetyloxybenzoic acid is the classic example of the chemical name for the common pain reliever aspirin. Option a is incorrect because the generic name is the common name assigned after the chemical name, is not capitalized unless starting a sentence, and other manufacturers may produce the drug under this name once the patent expires. Option c is incorrect because the brand or trade name is assigned by the manufacturer after the drug clears clinical trial phases one through three, is always capitalized, and is often followed by registered trademark symbols. Option d is incorrect because the official name must contain the same active ingredients as the brand name but may have different inactive fillers, and it functions as the recognized generic designation rather than the laboratory chemical composition.

Correct Answer: Brand or trade name

Option c is correct because the brand or trade name is assigned by the manufacturer after the drug clears phases one through three of clinical trials, is always capitalized, and is commonly followed by registered trademark or copyright symbols. Option a is incorrect because the chemical compound name is the very first name given during laboratory research showing the chemical composition, not a proprietary name assigned after clinical trials are completed by the manufacturer. Option b is incorrect because the generic common name is not proprietary to any manufacturer, is only capitalized at the beginning of sentences, and becomes available for other manufacturers to use once the original patent expires. Option d is incorrect because the official pharmacopeia name refers to the recognized generic designation that must contain the same active ingredients as the brand version, not a capitalized proprietary name with trademark symbols assigned by a manufacturer.

Correct Answer: Generic drug name

Option d is correct because the generic name is the common non-proprietary name other manufacturers may use once the patent expires, is only capitalized at sentence beginnings, and must share the same active ingredients though inactive fillers may differ. Option a is incorrect because the chemical laboratory name describes the molecular composition studied during initial research and is the very first name assigned, not the common name used by multiple manufacturers after patent expiration. Option b is incorrect because the brand or trade name is a proprietary name owned by the original manufacturer, always capitalized with trademark symbols, and is specific to that company's version rather than available for other manufacturers to use. Option c is incorrect because pharmacokinetic classification describes how drugs move through the body during absorption, distribution, metabolism, and excretion, not a naming convention used to identify medications across different manufacturers.

Correct Answer: Chemical, generic, official, trade

Option a is correct because drugs first receive a chemical name in the laboratory, then a generic common name, then an official name with the same active ingredients, and finally a brand or trade name after clearing all clinical trial phases. Option b is incorrect because this sequence places the trade name first, but the trade or brand name is actually the last name assigned to a drug after it has successfully completed all three phases of clinical trials and received manufacturer branding. Option c is incorrect because this sequence places the generic name before the chemical name, but the chemical name showing the molecular composition is always assigned first during initial laboratory research before any common name is designated. Option d is incorrect because this sequence places the official name first and the chemical name third, completely reversing the actual development timeline where the chemical name comes first during laboratory research and identification.

Correct Answer: Generic name standardization rules

Option b is correct because the generic or official name must have the same active ingredients as the brand name, meaning different manufacturers may produce versions with different fillers but identical therapeutic active components under the same generic name. Option a is incorrect because pharmacodynamic equivalence testing refers to studying drug effects on the body, not the naming convention that ensures different manufacturers' products share the same active ingredients under a common generic designation. Option c is incorrect because controlled substance scheduling classifies drugs by abuse potential and medical use under the Controlled Substances Act, not the rules governing how active ingredient equivalency is maintained across different drug manufacturers. Option d is incorrect because brand name trademark protection covers the proprietary name, capitalization, and symbols a manufacturer uses for marketing, not the underlying principle that ensures different generic vers